We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Summaries of safety labeling changes approved by FDA—boxed warnings highlights, April–June 2023.
- Abstract
The article presents a summary of revisions to the safety labeling of drugs and therapeutic biologicals including boxed warnings posted on the website of the U.S. Food and Drug Administration (FDA) as part of its MedWatch program in April-June 2023. Topics include some of the uses of boxed warnings and the new information contained in the revised boxed warnings for clozapine and hydroxyurea drugs.
- Subjects
UNITED States; SAFETY; DRUG efficacy; ORTHOSTATIC hypotension; LABELS; UNITED States. Food &; Drug Administration; DRUG labeling; CLOZAPINE; DRUG interactions; BRADYCARDIA
- Publication
American Journal of Health-System Pharmacy, 2023, Vol 80, Issue 19, p1297
- ISSN
1079-2082
- Publication type
Article
- DOI
10.1093/ajhp/zxad182